International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility.

Recently, a novel in vitro reconstructed skin micronucleus (RSMN) assay incorporating the EpiDerm 3D human skin model (Curren et al., Mutat. Res. 607 (2006) 192-204; Mun et al., Mutat. Res. 673 (2009) 92-99) has been shown to produce comparable data when utilized in three different laboratories in the United States (Hu et al., Mutat. Res. 673 (2009) 100-108). As part of a project sponsored by the European cosmetics companies trade association (COLIPA), with a contribution from the European Center for the Validation of Alternative Methods (ECVAM), international prevalidation studies of the RSMN assay have been initiated. The assay was transferred and optimized in two laboratories in Europe, where dose-dependent, reproducibly positive results for mitomycin C and vinblastine sulfate were obtained. Further intra- and inter-laboratory reproducibility of the RSMN assay was established by testing three coded chemicals, N-ethyl-N-nitrosourea, cyclohexanone, and mitomycin C. All chemicals were correctly identified by all laboratories as either positive or negative. These results support the international inter-laboratory and inter-experimental reproducibility of the assay and reinforce the conclusion that the RSMN assay in the EpiDerm 3D human skin model is a valuable in vitro method for assessment of genotoxicity of dermally applied chemicals.

[1]  B. Ames,et al.  The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program. , 1991, Environmental health perspectives.

[2]  Michael Balls,et al.  The Role of Prevalidation in the Development, Validation and Acceptance of Alternative Methods , 1995 .

[3]  Sac-fry Stages,et al.  OECD GUIDELINE FOR TESTING OF CHEMICALS , 2002 .

[4]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. , 2006, Mutation research.

[5]  M. Aardema,et al.  Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. , 2009, Mutation research.

[6]  E. Weisburger.  Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents , 1977, Cancer.

[7]  L. Marrot,et al.  Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds? , 2006, Mutation research.

[8]  T. Sofuni,et al.  The need for long-term treatment in the mouse lymphoma assay. , 1999, Mutagenesis.

[9]  Marilyn J Aardema,et al.  Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). , 2006, Mutation research.

[10]  R L Binder,et al.  Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  Mitchell Klausner,et al.  Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay. , 2009, Mutation research.

[12]  T Sofuni,et al.  Report from the In Vitro Micronucleus Assay Working Group. , 2003, Environmental and molecular mutagenesis.

[13]  David Kirkland,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.

[14]  Marilyn J Aardema,et al.  Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm human reconstructed epidermis model. , 2009, Toxicology letters.

[15]  J A Heddle,et al.  The mutagenic activity of 61 agents as determined by the micronucleus, Salmonella, and sperm abnormality assays. , 1979, Canadian journal of genetics and cytology. Journal canadien de genetique et de cytologie.

[16]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.

[17]  Flamand Nicole,et al.  再構築ヒト皮膚モデル,Episkinによる遺伝毒性試験手順の開発:経皮適用化合物のin vitroでの危険性評価のための新しいツールか? , 2006 .

[18]  M. Fenech.  The in vitro micronucleus technique. , 2000, Mutation research.

[19]  J. Ashby,et al.  Prediction of Salmonella mutagenicity. , 1996, Mutagenesis.